Orbactiv & Off label use

28.7%

of users reported Off label use

61.3%

also reported Severe reaction

59.9%

are women

Severe reaction

61.3%

Hospitalization

25.8%

Death

6.5%

Life-threatening condition

6.5%

Orbactiv: general information

30 - 39 years

14.9%

40 - 49 years

19.9%

50 - 59 years

23.5%

60 - 69 years

29.8%

70 - 79 years

8.3%

80 - 89 years

3.6%